 "Kiran Mazumdar-Shaw, CMD, Biocon")
Biotechnology major Biocon on Friday said its consolidated net profit rose an over two-fold to Rs 173 crore for the second quarter ended September 30, 2023.
The company had reported a net profit of Rs 82 crore for the July-September period of the last fiscal.
Total income rose to Rs 3,620 crore for the second quarter as against Rs 2,384 crore in the year-ago period, Biocon Ltd said in a regulatory filing.
Shares of the company on Friday ended 0.11 per cent higher at Rs 227.35 apiece on the BSE.
